The vaccine manufacturers in India, Dr Reddy's, have already submitted the safety and immunogenicity data of the third phase trialsDr Reddy’s had entered into a partnership with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik VDr Reddy's had applied for emergency approval for Sputnik V.
The company had conducted Phase 2 trials in India with around 1,500 participants. Phase 3 trials are still underway."We expect to get the approval in the next few weeks.
It is a two-dose vaccine. You take the first dose on day zero and the second one on day 21. The peak immunity develops somewhere between day 28 to day 42.